HealthEquity (FRA:2HE) Notes Receivable: €0 Mil (As of Apr. 2026)


FRA:2HE HealthEquity Inc FRA:2HE
93 GF Score
Price €83.00
GF Value €89.81
! 3 Warning Signs
View Full Analysis

What is HealthEquity Notes Receivable?

HealthEquity FRA:2HE +3.75% 93 Notes Receivable is €0 Mil as of Apr. 2026. GuruFocus rates FRA:2HE with a GF Score™ of 93/100 and a GF Value™ of €89.81. The stock has 3 warning signs investors should review.

HealthEquity's Notes Receivable for the quarter that ended in Apr. 2026 was €0 Mil.

HealthEquity Notes Receivable Historical Data

* Premium members only.

The historical data trend for HealthEquity's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthEquity Notes Receivable Chart

HealthEquity Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

HealthEquity Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:2HE
93GF Score
HealthEquity Inc FRA:2HE
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthEquity Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of €0 Mil mean?
HealthEquity (FRA:2HE) has a Notes Receivable of €0 Mil as of Apr. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on HealthEquity and its competitors.
Is HealthEquity's Notes Receivable too high?
HealthEquity's current Notes Receivable is €0 Mil. Overall, HealthEquity has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's Notes Receivable compare to HNGE and TEM?
HealthEquity's Notes Receivable of €0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on HealthEquity and its competitors. HealthEquity's current Notes Receivable is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (FRA:2HE) has a current Notes Receivable of €0 Mil. The stock's GF Value™ is €89.81, compared to a current price of €83.00 — trading 7.6% below its estimated fair value. The current Notes Receivable is €0 Mil. HealthEquity's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current Notes Receivable is €0 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthEquity (FRA:2HE) Overvalued in 2026?

Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued. The current stock price of €83.00 is trading 7.6% below its estimated GF Value™ of €89.81.

Key valuation signals for FRA:2HE:

  • Notes Receivable: €0 Mil
  • GF Value™: €89.81 vs. price of €83.00 (7.6% below fair value)
  • GF Score™: 93/100 with 3 warning signs

No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HealthEquity Business Description

Other Exchanges HQY:USA
Address 15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
93GF Score

Get the complete analysis for FRA:2HE

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€83.00
Price
€89.81
GF Value